EFFICACY AND TOLERABILITY OF PERAMPANEL AS ADDITIONAL DRUG OF TEENAGERS WITH DRUG-RESISTANT PARTIAL EPILEPSY: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY CONDUCTED IN THE RUSSIAN FEDERATION
Abstract
About the Author
E. D. BelousovaRussian Federation
References
1. Karlov V.A. Patofiziologija jepilepsii. V kn. Jepilepsija u detej i vzroslyh zhenshhin i muzhchin. Rukovodstvo dlja vrachej. M. 2010; 64-105.Chu-Shore C.J., Thiele E.A. New drugs for pediatric epilepsy. Semin Pediatr Neurol. 2010; 17: 214-23.
2. Fergus Rugg-Gunn. Adverse effects and safety profile of perampanel: A review of pooled data. Epilepsia. 2014; 55 (1): 13-15.
3. Johannessen Landmark C., Johannessen S.I. Pharmacological management of epilepsy: recent advances and future prospects. Drugs. 2008; 68 (14): 1925-39.
4. Kerling F., Kasper B.S. Efficacy of perampanel: a review of clinical trial data. Acta Neurol. Scand. 2013; 127 (197): 25-29.
5. Rogawski M.A. Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Currents. 2011; 11: 56-63.
6. Satlin A., Kramer L.D., Laurenza A. Development of perampanel in epilepsy. Acta Neurol. Scand. 2013; 127 (197): 3-8.
7. Schiller Y., Najjar Y. Quantifying the response to antiepileptic drugs: effect of past treatment history. Neurology. 2008; 70: 54-65.
8. Serratosa J.M., Villanueva V., Kerling F., Kasper B.S. Safety and tolerability of perampanel: a review of clinical trial data. Acta Neurol Scand. 2013; 127 (197): 30-35.
9. Steinhoff B.I. Efficacy of perampanel: A review of pooled data. Epilepsia. 2014; 55 (1): 9-12.
Review
For citations:
Belousova E.D. EFFICACY AND TOLERABILITY OF PERAMPANEL AS ADDITIONAL DRUG OF TEENAGERS WITH DRUG-RESISTANT PARTIAL EPILEPSY: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY CONDUCTED IN THE RUSSIAN FEDERATION. Epilepsy and paroxysmal conditions. 2014;6(1):27-33. (In Russ.)

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.